Global
# |
Name |
Interest Coverage Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
42,652.03
|
Dec. 31, 2023 | USD 2.82 | 2.48% |
|
China |
|
2 |
30,618.30
|
Dec. 31, 2023 | USD 3.44 | 0.58% |
|
Israel |
|
3 |
22,626.00
|
Dec. 31, 2023 | USD 1.63 | 0.49% |
|
||
4 |
19,489.40
|
March 31, 2024 | USD 2.09 | 5.36% |
|
India |
|
5 |
15,582.15
|
Dec. 31, 2023 | USD 6.64 | 6.03% |
|
China |
|
6 |
12,204.38
|
Dec. 31, 2023 | USD 2.64 | 3.93% |
|
China |
|
7 |
11,387.21
|
Dec. 31, 2023 | USD 2.61 | 3.57% |
|
China |
|
8 |
7,733.58
|
Dec. 31, 2023 | USD 2.60 | 1.18% |
|
China |
|
9 |
6,847.18
|
Dec. 31, 2023 | USD 1.04 | 1.87% |
|
China |
|
10 |
4,813.99
|
Dec. 31, 2023 | USD 0.94 | 3.63% |
|
China |
|
11 |
3,928.82
|
Sept. 30, 2024 | USD 1.58 | -17.28% |
|
United States |
|
12 |
3,271.94
|
Oct. 31, 2023 | USD 5.00 | -4.99% |
|
Japan |
|
13 |
3,185.27
|
Dec. 31, 2023 | USD 8.73 | 8.10% |
|
China |
|
14 |
3,102.99
|
Dec. 31, 2023 | USD 1.76 | 3.79% |
|
China |
|
15 |
2,935.57
|
July 31, 2023 | USD 1.94 | -0.83% |
|
Japan |
|
16 |
2,571.58
|
Dec. 31, 2023 | USD 11.90 | 21.74% |
|
South Korea |
|
17 |
1,801.08
|
Dec. 31, 2023 | USD 3.27 | 2.18% |
|
China |
|
18 |
1,586.49
|
Dec. 31, 2023 | USD 116.36 | -0.45% |
|
Germany |
|
19 |
1,316.18
|
March 31, 2024 | USD 10.63 | 4.05% |
|
India |
|
20 |
1,243.91
|
Dec. 31, 2023 | USD 3.74 | 2.82% |
|
China |
|
21 |
1,243.47
|
Dec. 31, 2023 | USD 1.15 | 2.95% |
|
China |
|
22 |
1,091.24
|
Dec. 31, 2023 | USD 2.91 | -0.09% |
|
Taiwan |
|
23 |
1,049.31
|
Dec. 31, 2023 | USD 4.44 | -0.90% |
|
Taiwan |
|
24 |
965.94
|
June 30, 2024 | USD 70.50 | 0.61% |
|
Denmark |
|
25 |
915.13
|
Dec. 31, 2023 | USD 0.89 | 2.52% |
|
China |
|
26 |
910.64
|
Dec. 31, 2023 | USD 20.08 K | 0.04% |
|
France |
|
27 |
904.08
|
Dec. 31, 2023 | USD 0.72 | 5.40% |
|
China |
|
28 |
902.84
|
Dec. 31, 2023 | USD 23.99 | 3.90% |
|
China |
|
29 |
842.19
|
Dec. 31, 2023 | USD 60.50 | -1.24% |
|
Germany |
|
30 |
817.74
|
Dec. 31, 2023 | USD 9.77 | 0.05% |
|
China |
|
31 |
730.51
|
Dec. 31, 2023 | USD 17.87 | 3.09% |
|
Sweden |
|
32 |
728.77
|
Dec. 31, 2023 | USD 8.51 | 2.10% |
|
China |
|
33 |
721.67
|
March 31, 2024 | USD 69.21 | 4.65% |
|
India |
|
34 |
713.19
|
Dec. 31, 2023 | USD 6.04 | 3.46% |
|
China |
|
35 |
668.39
|
Dec. 31, 2023 | USD 2.28 | 6.43% |
|
China |
|
36 |
649.59
|
Dec. 31, 2023 | USD 3.24 | 2.11% |
|
China |
|
37 |
631.84
|
Dec. 31, 2023 | USD 1.34 | 5.04% |
|
China |
|
38 |
582.41
|
Dec. 31, 2023 | USD 4.94 | 3.02% |
|
China |
|
39 |
580.52
|
Dec. 31, 2023 | USD 9.75 | -0.95% |
|
Sweden |
|
40 |
442.84
|
Dec. 31, 2023 | USD 3.99 | 1.96% |
|
China |
|
41 |
405.84
|
Dec. 31, 2023 | USD 10.09 | 5.71% |
|
China |
|
42 |
395.10
|
Dec. 31, 2023 | USD 1.55 | 3.64% |
|
China |
|
43 |
385.08
|
Dec. 31, 2023 | USD 7.16 | 2.79% |
|
China |
|
44 |
352.53
|
Dec. 31, 2023 | USD 61.01 | 0.32% |
|
Switzerland |
|
45 |
347.54
|
Dec. 31, 2023 | USD 1.36 | 33.77% |
|
Norway |
|
46 |
344.35
|
Dec. 31, 2023 | USD 0.93 | -0.21% |
|
Taiwan |
|
47 |
343.54
|
Dec. 31, 2023 | USD 8.44 | 1.77% |
|
China |
|
48 |
317.29
|
Dec. 31, 2023 | USD 15.35 | 4.46% |
|
China |
|
49 |
313.48
|
Dec. 31, 2023 | USD 1.14 | 2.84% |
|
China |
|
50 |
300.30
|
Dec. 31, 2023 | USD 2.65 | 1.42% |
|
China |
The Biotechnology company with the highest Interest Coverage Ratio is Yantai Zhenghai Biotechnology Co., Ltd. (Shenzhen Stock Exchange: 300653.SZ) at 42,652.03.
The Biotechnology company with the lowest Interest Coverage Ratio is Lexaria Bioscience Corp. (NasdaqCM: LEXX) at -7,281,662.00.
The top 10 Biotechnology companies the Global by Interest Coverage Ratio are Yantai Zhenghai Biotechnology Co., Ltd., Scinai Immunotherapeutics Ltd., G&E Herbal Biotechnology Co., Ltd., Agri-tech (India) Limited, Giant Biogene Holding Co., Ltd., Vcanbio Cell & Gene Engineering Corp., Ltd, Caina Technology Co., Ltd., Chengdu Kanghong Pharmaceutical Group Co., Ltd, Beijing SL Pharmaceutical Co., Ltd. and Shanghai RAAS Blood Products Co., Ltd..
The bottom 10 Biotechnology companies by Interest Coverage Ratio are Lexaria Bioscience Corp., MAIA Biotechnology, Inc., Creative Medical Technology Holdings, Inc., Synlogic, Inc., MEDINET Co., Ltd., Kodiak Sciences Inc., Roquefort Therapeutics plc, NextCell Pharma AB, ESSA Pharma Inc. and Arcturus Therapeutics Holdings Inc..